Ene CI, Singh S, Venkataraman T, Phillips LM, et al. Systemic immune correlates of long-term survival after Delta-24-RGD based on the Therapeutic Adenovirus for Recurrent Glioblastoma Effect Trial (TARGET). Clin Cancer Res 2026 Jan 29. doi: 10.1158/1078-0432.CCR-25-3566.
PMID: 41609523